Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1951 2
1952 2
1953 2
1954 1
1955 5
1956 4
1957 7
1958 3
1959 2
1960 7
1961 17
1962 21
1963 19
1964 25
1965 30
1966 27
1967 29
1968 28
1969 39
1970 33
1971 43
1972 58
1973 52
1974 60
1975 56
1976 41
1977 56
1978 82
1979 98
1980 99
1981 111
1982 140
1983 172
1984 146
1985 189
1986 184
1987 187
1988 197
1989 229
1990 224
1991 215
1992 266
1993 297
1994 293
1995 259
1996 319
1997 274
1998 338
1999 347
2000 373
2001 417
2002 395
2003 411
2004 426
2005 467
2006 543
2007 526
2008 515
2009 472
2010 541
2011 602
2012 659
2013 644
2014 644
2015 633
2016 609
2017 647
2018 688
2019 670
2020 771
2021 889
2022 826
2023 781
2024 765
2025 824
2026 412

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19,643 results

Results by year

Filters applied: . Clear all
Page 1
In Response.
Pak A, Butt A, Tanaka KA, Stewart KE. Pak A, et al. Among authors: tanaka ka. Anesth Analg. 2026 Feb 1;142(2):e4. doi: 10.1213/ANE.0000000000007793. Epub 2025 Nov 6. Anesth Analg. 2026. PMID: 41201440 No abstract available.
IFITM3-MET interaction drives osimertinib resistance through AKT pathway activation in EGFR-mutant non-small cell lung cancer.
Ibusuki R, Iwama E, Shimauchi A, Kawano H, Mizusaki S, Nakamura S, Miyazaki Y, Inutsuka Y, Hashisako M, Harada T, Tsuchiya-Kawano Y, Tsutsumi H, Nakanishi T, Nakagaki N, Koga Y, Kimura S, Mashimoto S, Shibahara D, Otsubo K, Yoneshima Y, Tanaka K, Oda Y, Okamoto I. Ibusuki R, et al. Among authors: tanaka k. Mol Cancer. 2025 Oct 28;24(1):272. doi: 10.1186/s12943-025-02493-6. Mol Cancer. 2025. PMID: 41152910 Free PMC article.
Non-central chirality in organic chemistry.
Tanaka K, Yoshikai N. Tanaka K, et al. Beilstein J Org Chem. 2026 Feb 24;22:370-371. doi: 10.3762/bjoc.22.24. eCollection 2026. Beilstein J Org Chem. 2026. PMID: 41777235 Free PMC article. No abstract available.
Spatial single-cell proteotyping reveals immunotherapy-resistant features within the complex tumor microenvironment of metastatic NSCLC.
Isomoto K, Haratani K, Tsujikawa T, Tomida S, Makutani Y, Takeda M, Yonesaka K, Tanaka K, Iwasa T, Sakai K, Nishio K, Ito A, Nakagawa K, Hayashi H. Isomoto K, et al. Among authors: tanaka k. J Clin Invest. 2026 Mar 10;136(10):e195021. doi: 10.1172/JCI195021. eCollection 2026 May 15. J Clin Invest. 2026. PMID: 41805727 Free PMC article.
Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin-Based Tumor Marker Score for First-Line Immunotherapy Selection in Hepatocellular Carcinoma.
Tanaka K, Tsuji K, Hiraoka A, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Ishikawa T, Tajiri K, Ochi H, Toyoda H, Koshiyama Y, Ogawa C, Nishikawa H, Nishimura T, Hatanaka T, Kakizaki S, Noritake H, Kawata K, Naganuma A, Kosaka H, Matsui K, Matono T, Kuroda H, Yata Y, Tanaka H, Aoki T, Tamai H, Tada F, Ohama H, Kanayama Y, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Yoshida O, Imai M, Nakamura S, Enomoto H, Kaibori M, Kudo M, Hiasa Y, Kumada T; Real-life Practice Experts for HCC (RELPEC) Study Group; HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan). Tanaka K, et al. Liver Cancer. 2025 Jul 21;15(2):205-221. doi: 10.1159/000547519. eCollection 2026 May. Liver Cancer. 2025. PMID: 41063740 Free PMC article.
Effects of finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR).
Tanaka A, Vaduganathan M, Imai T, Okada Y, Sonoda S, Torimoto K, Suwa S, Teragawa H, Miyazono M, Fukuda M, Yonezu K, Takahashi N, Yoshida Y, Tanaka K, Shimabukuro M, Hotta Y, Moroi M, Niikura H, Kida K, Yokota K, Fukuda D, Tanabe K, Horiuchi Y, Toyoda S, Taguchi I, Yoshida H, Miyoshi T, Nangaku M, Shibata H, Node K; FIVE-STAR Investigators. Tanaka A, et al. Among authors: tanaka k. Cardiovasc Diabetol. 2025 Dec 5;24(1):454. doi: 10.1186/s12933-025-03014-x. Cardiovasc Diabetol. 2025. PMID: 41351003 Free PMC article. Clinical Trial.
Randomized open-label non-inferiority trial of paracetamol or celecoxib for patients with chronic low back pain.
Hayashi K, Miki K, Ueno H, Sekiguchi M, Arai YC, Nikaido T, Shiga Y, Inoue M, Kataoka H, Kawarai Y, Kimura Y, Shimizu K, Shimo K, Shiro Y, Tanaka K, Tanaka S, Hirakawa Y, Miura K, Yukioka M. Hayashi K, et al. Among authors: tanaka k. Sci Rep. 2025 Dec 9;16(1):1577. doi: 10.1038/s41598-025-31094-y. Sci Rep. 2025. PMID: 41366055 Free PMC article. Clinical Trial.
Regnase-1-mediated regulation of neutrophils modulates SARS-CoV-2 pneumonia.
Yasuda K, Aoki J, Tanaka K, Shichinohe S, Ono C, Vandenbon A, Ohara D, Muramoto Y, Li S, Motooka D, Watanabe H, Hirota K, Kondoh G, Noda T, Standley DM, Ikehara Y, Okada S, Watanabe T, Matsuura Y, Takeuchi O. Yasuda K, et al. Among authors: tanaka k. PLoS Pathog. 2026 Feb 9;22(2):e1013969. doi: 10.1371/journal.ppat.1013969. eCollection 2026 Feb. PLoS Pathog. 2026. PMID: 41662396 Free PMC article.
19,643 results
You have reached the last available page of results. Please see the User Guide for more information.